Stockscreener 앱 받기
11.52
2.77%
0.31
시간 외 거래:
11.52
전일 마감가:
$11.21
열려 있는:
$11.25
하루 거래량:
586.12K
Relative Volume:
2.20
시가총액:
$576.02M
수익:
$62.02M
순이익/손실:
$-45.65M
주가수익비율:
-12.52
EPS:
-0.92
순현금흐름:
$-9.60M
1주 성능:
+5.69%
1개월 성능:
+2.67%
6개월 성능:
+23.87%
1년 성능:
+50.00%
1일 변동 폭
$11.20
$11.67
1주일 범위
$10.82
$11.67
52주 변동 폭
$7.44
$11.88
Theravance Biopharma Inc Stock (TBPH) Company Profile
명칭
Theravance Biopharma Inc
전화
650-808-6000
주소
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
TBPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TBPH
Theravance Biopharma Inc
|
11.52 | 559.01M | 62.02M | -45.65M | -9.60M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-04-12 | 개시 | BTIG Research | Buy |
| 2024-01-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2021-11-05 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-15 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2021-08-25 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2021-08-24 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-10-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-07 | 개시 | JP Morgan | Overweight |
| 2020-06-15 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-05-13 | 개시 | Cowen | Outperform |
| 2020-01-08 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-06 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
| 2019-10-29 | 개시 | H.C. Wainwright | Buy |
| 2018-03-29 | 재개 | Piper Jaffray | Overweight |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-06-16 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-05-11 | 재확인 | Needham | Buy |
| 2016-12-21 | 개시 | Needham | Buy |
| 2016-11-03 | 개시 | Piper Jaffray | Overweight |
| 2016-10-12 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2016-08-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2016-06-20 | 개시 | Guggenheim | Buy |
| 2016-06-20 | 재확인 | Leerink Partners | Outperform |
| 2016-05-12 | 개시 | Leerink Partners | Outperform |
| 2016-05-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2015-02-03 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
모두보기
Theravance Biopharma Inc 주식(TBPH)의 최신 뉴스
What is the dividend policy of Theravance Biopharma Inc. stockInvest confidently with professional market insights - Jammu Links News
Is Theravance Biopharma Inc. stock overvalued or undervaluedInvest confidently with actionable market data - Jammu Links News
What are the latest earnings results for Theravance Biopharma Inc.Maximize gains with timely market signals - Jammu Links News
What are the technical indicators suggesting about Theravance Biopharma Inc.High-velocity gains - Jammu Links News
How volatile is Theravance Biopharma Inc. stock compared to the marketBreakthrough profits - Jammu Links News
What analysts say about Theravance Biopharma Inc. stockSuperior returns - Jammu Links News
Should I hold or sell Theravance Biopharma Inc. stock in 2025Build a diversified portfolio for risk management - Jammu Links News
What makes Theravance Biopharma Inc. stock price move sharplyInvest confidently with professional market insights - Jammu Links News
What is Theravance Biopharma Inc. company’s growth strategyMaximize your gains with professional insights - Jammu Links News
What drives Theravance Biopharma Inc. stock priceAchieve rapid returns with smart investment plans - Jammu Links News
How strong is Theravance Biopharma Inc. company’s balance sheetAchieve breakthrough results with expert guidance - Jammu Links News
Why is Theravance Biopharma Inc. stock attracting strong analyst attentionHigh-profit capital plays - Jammu Links News
What earnings revisions data tells us about Theravance Biopharma Inc.AI Generated Momentum Stock Forecast Guide - Newser
Theravance Biopharma Inc.’s volatility index tracking explainedMulti-Year Investment Performance Summary Report - Newser
Published on: 2025-08-02 00:08:08 - Newser
Applying Wyckoff theory to Theravance Biopharma Inc. stockSwing Entry Insight With Forecast Accuracy - Newser
Theravance Biopharma Inc. stock chart pattern explainedWeekly High Conviction Trade Setup Analysis - Newser
Published on: 2025-08-02 07:06:55 - beatles.ru
Theravance Biopharma Inc. Stock Performance After Earnings: Historical InsightsFree Trade Setups With Clear Risk Limits - Newser
Using RSI to spot recovery in Theravance Biopharma Inc.Free Pattern Breakout Entry Stock Forecast - Newser
Bank of New York Mellon Corp Boosts Stake in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Using Ichimoku Cloud for Theravance Biopharma Inc. technicalsFree Low Capital High Return Stock Plans - Newser
Is Theravance Biopharma Inc. stock a good hedge against inflationConservative Asset Allocation Risk Analysis - Newser
What is the risk reward ratio of investing in Theravance Biopharma Inc. stockBreakout Stocks Updates With Proven Results - Jammu Links News
What’s the recovery path for long term holders of Theravance Biopharma Inc.Early Breakout Entry Point Notifications Sent - metal.it
How Theravance Biopharma Inc. stock performs during market volatilityValue Holding Return Summary With Outlook - Newser
How to use a screener to detect Theravance Biopharma Inc. breakoutsFree Stable Entry High Return Opportunities - Newser
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Bought by GSA Capital Partners LLP - Defense World
What institutional flow reveals about Theravance Biopharma Inc.Trade Flow Monitor with Volume Tracker - Newser
How does Theravance Biopharma Inc. compare to its industry peersSwing Trade Review With Proven Results - jammulinksnews.com
Theravance Biopharma Inc (TBPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):